APOC4 and hepatocellular carcinoma: In this study, we identified eight RS HDRGs (namely, FMO3, ALDH5A1, HSD17B6, APOC4, PON1, ITIH1, A1BG, and ANG) and explored the impact of HDRGs on OS of patients with HCC.